Collectively, our results implicate SLC27A5 and tyrosine-metabolizing enzymes as acting as tumor suppressor in HCC and coordinating lipid and tyrosine metabolism, which may be potential targets in HCC treatment. This evidence concerns the gene SLC27A5 and neoplasm.